Tryp Therapeutics Inc.
TRYPF · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Market Cap | $6,512 | $13,818 | $30,697 | $39,444 |
| - Cash | $345 | $1,796 | $3,692 | $1,019 |
| + Debt | $2,103 | $0 | $0 | $5 |
| Enterprise Value | $8,270 | $12,022 | $27,004 | $38,429 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,702 | -$7,230 | -$6,311 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$5,267 | -$7,495 | -$8,255 | -$423 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.055 | -0.096 | -0.12 | -0.011 |
| % Growth | 43.1% | 20% | -990.9% | – |
| Operating Cash Flow | -$3,622 | -$5,809 | -$5,063 | -$36 |
| Capital Expenditures | -$8 | -$138 | -$25 | -$4 |
| Free Cash Flow | -$3,630 | -$5,947 | -$5,087 | -$41 |